Among many genes in this pathway, SKP2 was found over-expressed in basal-like tumors; it encodes a protein involved in the degradation of another cyclin-dependent kinase inhibitor p27 (CDKN1B) and recently reported to be over-expressed in many tumor types and to correlate with poor prognosis [22,23]. The gene discussed is CDKN3; the disease is neoplasm.